TTBIO CORP.(TW:6493)
NT$28.80-0.25 (-0.86%)
TW:6493
TTBIO CORP. financials statements
NT$28.80
At close:-0.25 (-0.86%)
TTBIO CORP. (6493) Financial Statements
TTBIO CORP. Financial Overview
TTBIO CORP.'s market cap is currently NT$872.95M. The company's EPS TTM is NT$-0.55; its P/E ratio is -52.82; and it has a dividend yield of 0.69%. TTBIO CORP. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 398.88M | NT$ 312.12M | NT$ 318.09M | NT$ 418.88M | NT$ 305.52M |
| Gross Profit | NT$ 49.76M | NT$ 72.77M | NT$ 78.42M | NT$ 122.53M | NT$ 90.45M |
| Operating Income | NT$ -21.23M | NT$ -2.29M | NT$ -862.00K | NT$ 38.36M | NT$ 12.26M |
| EBITDA | NT$ 14.81M | NT$ 47.19M | NT$ 52.11M | NT$ 89.29M | NT$ 52.58M |
| Net Income | NT$ -21.30M | NT$ 2.59M | NT$ 6.68M | NT$ 39.80M | NT$ 11.53M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 59.28M | NT$ 90.31M | NT$ 59.36M | NT$ 113.05M | NT$ 70.10M |
| Total Assets | NT$ 622.44M | NT$ 608.29M | NT$ 511.86M | NT$ 526.72M | NT$ 464.73M |
| Total Debt | NT$ 175.11M | NT$ 212.43M | NT$ 144.61M | NT$ 125.75M | NT$ 75.91M |
| Net Debt | NT$ 121.36M | NT$ 129.84M | NT$ 85.25M | NT$ 12.71M | NT$ 5.81M |
| Total Liabilities | NT$ 265.06M | NT$ 313.18M | NT$ 212.17M | NT$ 203.61M | NT$ 169.26M |
| Stockholders' Equity | NT$ 357.38M | NT$ 295.11M | NT$ 299.69M | NT$ 323.11M | NT$ 295.47M |
| Cash Flow | |||||
| Free Cash Flow | NT$ -50.01M | NT$ 16.51M | NT$ -39.24M | NT$ 8.81M | NT$ 30.47M |
| Operating Cash Flow | NT$ -41.01M | NT$ 25.35M | NT$ 4.00M | NT$ 50.11M | NT$ 47.13M |
| Investing Cash Flow | NT$ -8.97M | NT$ -10.91M | NT$ -48.34M | NT$ -43.67M | NT$ -16.30M |
| Financing Cash Flow | NT$ 21.13M | NT$ 8.79M | NT$ -9.34M | NT$ 36.51M | NT$ -2.87M |
Currency in TWD
